Direct-to-Consumer (DTC) Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomic Testing, Skincare Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) chips,

Direct-to-Consumer (DTC) Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomic Testing, Skincare Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) chips, Whole Genome Sequencing (WGS)), By Distribution Channel (Online Platforms, Over-the-Counter), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032

Direct-to-Consumer (DTC) Genetic Testing Market is anticipated to gain substantial growth between 2023 and 2032, primarily due to the rising disposable incomes, especially in emerging countries. For instance, a report claims that between 2019 and 2030, the annual disposable income, ranging from USD 45,000 to USD 100,000 will increase by more than 5.5% per year.

Besides, the increasing awareness about the detection and diagnosis of hereditary and rare genetic diseases among the general populace across the globe will also fuel the market demand. Furthermore, experts in the field believe that genetic testing will become a regular part of clinical care, which will also favor the market in the foreseeable future.

In addition, the key providers in the DTC genetic testing industry are also seeking to strengthen their foothold in the market by investing in R&D projects and engaging in meaningful mergers, acquisitions, and joint ventures. To cite an instance, in December 2022, it was reported that researchers at the BC Cancer Research Institute have advanced genetic testing procedures, which allows better identification of those genes that can eventually lead to cancer.

Overall, the DTC genetic testing market has been segmented in terms of test, technology, distribution channel, and region.

Based on the test, the nutrigenomic testing segment is anticipated to grow significantly over the next ten years, and by 2032 this segment should grow at over 13.5% CAGR. Nutrigenomic testing boasts of advantages such as identifying locations of metabolic weakness, understanding the safety profile and toxicity of micro and macronutrients, and preventing diet diseases.

On the basis of technology, the market growth is likely to be characterized by the whole genome sequencing segment. The segmental growth can be credited to the increasing cases of rare genetic disorders. Besides, the technology is also being widely accepted as it provides a base-by-base view and a high resolution of the genome, apart from accessing large data and identifying potential causes, which will further fuel the market demand through 2032.

In terms of the distribution channel, the online platform segment is anticipated to grow at a robust rate through 2023-2032, owing to the increasing number of online websites which facilitate direct-to-consumer genetic testing.

In the regional context, the North America DTC genetic testing market is anticipated to be valued at more than USD 4.9 billion by 2032 end. The regional market growth can be attributed to the increasing usage of DTC genetic tests in the region since they have reduced the mortality rates of patients.